Thrombotic complications of patients admitted to intensive care with COVID-19 at a teaching hospital in the United Kingdom

W Thomas, J Varley, A Johnston… - Thrombosis …, 2020 - thrombosisresearch.com
COVID-19 has been linked to coagulopathy and also thrombotic risk [1–4]. There have been
3 significant studies published of patients admitted to intensive care units (ICU) with COVID …

Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection

AT Obi, GD Barnes, LM Napolitano, PK Henke… - Journal of Vascular …, 2021 - Elsevier
Objective Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
virus confers a risk of significant coagulopathy, with the resulting development of venous …

[HTML][HTML] Surviving Covid-19 with heparin?

H Ten Cate - New England Journal of Medicine, 2021 - Mass Medical Soc
Patients who are admitted to the hospital with coronavirus disease 2019 (Covid-19) are at
high risk for thrombosis, particularly venous thromboembolism (VTE). In a meta-analysis of …

[HTML][HTML] Venous thrombosis and arteriosclerosis obliterans of lower extremities in a very severe patient with 2019 novel coronavirus disease: a case report

B Zhou, J She, Y Wang, X Ma - Journal of thrombosis and thrombolysis, 2020 - Springer
The outbreak of 2019 novel coronavirus disease (COVID-19) began since early December
2019, and has been declared as a public health emergency by the World Health …

[HTML][HTML] Prevalence of venous thromboembolism in critically ill patients with COVID‐19

JA Hippensteel, EL Burnham… - British journal of …, 2020 - ncbi.nlm.nih.gov
Results One‐hundred and six patients were admitted to the University of Colorado Hospital
in Aurora, CO, between 18 March and 14 April 2020. One patient developed nosocomial …

[HTML][HTML] Pulmonary embolism or thrombosis in ARDS COVID-19 patients: A French monocenter retrospective study

D Contou, O Pajot, R Cally, E Logre, M Fraissé… - PloS one, 2020 - journals.plos.org
Hypercoagulability and endotheliopathy reported in patients with coronavirus disease 2019
(COVID-19) combined with strict and prolonged immobilization inherent to deep sedation …

Incidence and outcomes of thrombotic events in symptomatic patients with COVID-19

A Elbadawi, IY Elgendy, A Sahai… - … , and vascular biology, 2021 - Am Heart Assoc
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome
(SARS-CoV-2) is associated with a heightened risk of thrombotic events. 1 We sought to …

[HTML][HTML] SARS-2 Coronavirus–Associated Hemostatic Lung Abnormality in COVID-19: Is It Pulmonary Thrombosis or Pulmonary Embolism?

J Thachil, A Srivastava - Seminars in thrombosis and …, 2020 - thieme-connect.com
The coronavirus disease 2019 (COVID-19) pandemic has claimed several thousand lives
since the first case was described in Wuhan, China, in December 2019. 1 This has mainly …

[HTML][HTML] Incidence of thrombotic complications in COVID-19: on behalf of ICODE: The International COVID-19 Thrombosis Biomarkers Colloquium

WJ Jenner, DA Gorog - Journal of thrombosis and thrombolysis, 2021 - Springer
A high incidence of thrombosis in hospitalised patients with COVID-19 was identified early
during the pandemic. Accurately quantifying thrombotic risk may assist prognosis and guide …

Coagulation abnormalities and thrombosis in patients infected with SARS-CoV-2 and other pandemic viruses

N Mackman, S Antoniak, AS Wolberg… - … , and vascular biology, 2020 - Am Heart Assoc
The world is amid a pandemic caused by severe acute respiratory syndrome-coronavirus 2.
Severe acute respiratory syndrome-coronavirus causes serious respiratory tract infections …